Observed by APhA and ASHP since 2023, bipartisan support has garnered to give pharmacy workforce suicide awareness its own federally recognized day.
|Articles|October 14, 2022
Year in Review: Take Our Survey
Share your thoughts on this year in review.
Advertisement
For the third year, Drug Topics® has partnered with LexisNexis Risk Solutions to take the pulse of pharmacists across the United States. From the continuing impacts of the COVID-19 pandemic on pharmacy practice to the role of clinical services, social determinants of health data, and beyond, we want to hear your opinion.
Click here to participate in our
Advertisement
Related to this article
Chad Worz, PharmD, BCGP, FASCP, discusses the Main Street Pharmacy Access Act, a revolutionary pharmacy-focused bill moving through Congress.
Digital innovation and proactive patient care are converging to transform clinical practice while preserving essential safeguards.
As pouched products increase in popularity, researchers assess their pharmacology, harm-reduction potential, and initiation risk.
In part 2, Vanessa Slowey explains the pharmacy industry’s need for due diligence as technology reinforces patient convenience in the 21st century.
In this episode, Shawn Bjorndal, PharmD, RPh, and Jesse McCullough, PharmD, explore rhythms, routines and how they can make or break pharmacy team members.
Vanessa Slowey lays the ground for where AI and automation are impacting pharmacy practice today and discusses what innovations are still expected.
Atogepant reduced migraine days during the perimenstrual period, positioning the medication as a potential first treatment option for the condition.
Advertisement
Advertisement
Trending on Drug Topics
1
Johnson & Johnson Next Major Drugmaker to Require 340B Claims Data
2
Generic Drug Costs Burdening Patients as Much as Brand Name Options
3
How the Main Street Pharmacy Access Act Advances Pharmacist Provider Status
4
Pharmacy Workforce Suicide Awareness Day Aiming for Federal Recognition
5